Bruno Geloneze
Bruno Geloneze
Obesity and Comorbities Research Center (OCRC) University of Campinas (UNICAMP)
E-mail confirmado em
Citado por
Citado por
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
ISE Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus ...
New England Journal of Medicine 373 (22), 2117-28, 2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
M SP, D GH, Brown-Frandsen K, K P, M JF, N MA, N SE, P S, P NR, R LS, ...
New England Journal of Medicine 375 (4), 311-322, 2016
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
MM Wanner C1, Inzucchi SE1, Lachin JM1, Fitchett D1, von Eynatten M1, ...
New England Journal of Medicine 375 (4), 323-334, 2016
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
MKW Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM ...
New England Journal of Medicine 380 (24), 2295-2306, 2019
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
WJP Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau ...
New England Journal of Medicine 373 (1), 11-22, 2015
IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
AC Sposito, B Caramelli, FAH Fonseca, MC Bertolami, A Afiune Neto, ...
Arquivos brasileiros de cardiologia 88, 2-19, 2007
Long-term weight regain after gastric bypass: a 5-year prospective study
DO Magro, B Geloneze, R Delfini, BC Pareja, F Callejas, JC Pareja
Obesity surgery 18 (6), 648-651, 2008
Liraglutide and Renal Outcomes in Type 2 Diabetes
BJB Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S ...
New England Journal of Medicine 377 (9), 839-848, 2017
The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 …
MLMP Jorge, VN de Oliveira, NM Resende, LF Paraiso, A Calixto, ...
Metabolism 60 (9), 1244-1252, 2011
Pratical recommendations for the management of diabetes in patients with COVID-19
SR Bernstein, F Rubino, K Khunti, G Mingrone, D Hopkins, AL Birkenfeld, ...
The Lancet Diabetes & Endocrinology, 00, 2020
I Diretriz sobre o consumo de gorduras e saúde cardiovascular
RD Santos, ACM Gagliardi, HT Xavier, CD Magnoni, R Cassani, ...
Arquivos Brasileiros de Cardiologia 100 (1), 1-40, 2013
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26 …
BMK Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M ...
Diabetes Care 35 (2), 252-8, 2012
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
PSX le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz ...
Lancet 140 (17), 30069-7, 2017
HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)
B Geloneze, ACJ Vasques, CFC Stabe, JC Pareja, LEFP Rosado, ...
Arquivos Brasileiros de Endocrinologia & Metabologia 53 (2), 281-287, 2009
The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study.
B Geloneze, EM Repetto, SR Geloneze, MA Tambascia, MN Ermetice
Diabetes Research and Clinical Practice 72 (2), 219, 2006
Ghrelin: a gut-brain hormone: effect of gastric bypass surgery
B Geloneze, MA Tambascia, VF Pilla, SR Geloneze, EM Repetto, ...
Obesity surgery 13 (1), 17-22, 2003
Neck Circumference as a Simple Tool for Identifying the Metabolic Syndrome and Insulin Resistance: Results from the Brazilian Metabolic Syndrome Study (BRAMS)
C Stabe, ACJ Vasques, MMO Lima, MA Tambascia, JC Pareja, ...
Clinical Endocrinology, 2012
Avaliação laboratorial e diagnóstico da resistência insulínica; Laboratorial evaluation and diagnosis of insulin resistance
B Geloneze, MA Tambascia
Arq. bras. endocrinol. metab 50 (2), 208-215, 2006
Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome
L Bahia, LG Aguiar, N Villela, D Bottino, AF Godoy-Matos, B Geloneze, ...
Clinics 61 (5), 433-440, 2006
TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study
ACJ Vasques, FS Novaes, MS de Oliveira, JRM Souza, A Yamanaka, ...
Diabetes research and clinical practice 93 (3), e98-e100, 2011
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20